CGTX

CGTX

USD

Cognition Therapeutics Inc. Common Stock

$0.317+0.002 (0.698%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$0.315

最高价

$0.315

最低价

$0.306

成交量

0.54M

公司基本面

市值

19.7M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

1.07M

交易所

NCM

货币

USD

52周价格范围

最低价 $0.222当前价 $0.317最高价 $2.535

相关新闻

GlobeNewswire

Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,

查看更多
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
GlobeNewswire

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies

PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released

查看更多
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.

查看更多
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3